JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 9 No. 1 16-18
© 1968 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhoton, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhoton, A. L.

Chlormerodrin-197Hg Brain Scanning: Selecting the Optimal Interval between Isotope Administration and Scanning

Albert L. Rhoton

Mayo Clinic and Mayo Foundation, Rochester, Minnesota

ABSTRACT

Twenty-five patients with abnormal uptake on brain scans made with chlormerodrin-197Hg were studied to determine the optimal interval between isotope administration and scanning. Twenty patients had tumors, and five had cerebral infarcts. Eighteen of the 20 tumors had optimal tumor-to-non-tumor ratios of counting rates 3–5 hr after injection. All five cerebral infarcts were optimally displayed 3–5 hr after injection. None of the counting times was extended beyond 5 hr.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1968 by the Society of Nuclear Medicine.